A Phase 2, Single Arm Study Evaluating the Efficacy and Safety of Idelalisib in Combination with Rituximab in Patients with Previously Untreated Chronie Lymphocytic Leukemia with 17p Deletion

Administered By

Awarded By

Contributors

Start/End

  • November 10, 2014 - November 9, 2019